(Q54392858)

29 May 2018

title

A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells. (English)

1 reference

29 May 2018

0 references

9

Yataro Daigo

1 reference

29 May 2018

author name string

Yusuke Tomita

1

1 reference

29 May 2018

Katsunori Imai

2

1 reference

29 May 2018

Satoru Senju

3

1 reference

29 May 2018

Atsushi Irie

4

1 reference

29 May 2018

Mitsuhiro Inoue

5

1 reference

29 May 2018

Yuki Hayashida

6

1 reference

29 May 2018

Kenji Shiraishi

7

1 reference

29 May 2018

Takeshi Mori

8

1 reference

29 May 2018

Takuya Tsunoda

10

1 reference

29 May 2018

Takaaki Ito

11

1 reference

29 May 2018

Hiroaki Nomori

12

1 reference

29 May 2018

Yusuke Nakamura

13

1 reference

29 May 2018

Hirotsugu Kohrogi

14

1 reference

29 May 2018

Yasuharu Nishimura

15

1 reference

29 May 2018

publication date

10 February 2011

1 reference

29 May 2018

published in

Cancer Science

1 reference

29 May 2018

volume

102

1 reference

29 May 2018

page(s)

697-705

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

Global cancer statistics, 2002

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Immunotherapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Identification of tumour-associated T-cell epitopes for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

The human GINS complex associates with Cdc45 and MCM and is essential for DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Human Cdc45 is a proliferation-associated antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

mRNA expression of the DNA replication-initiation proteins in epithelial dysplasia and squamous cell carcinoma of the tongue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Gene cloning of immunogenic antigens overexpressed in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Identification of SPARC as a candidate target antigen for immunotherapy of various cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Identification of a novel human cancer/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Genetic diversity of HLA-A2: evolutionary and functional significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.01865.X

10.1111/J.1349-7006.2011.01865.X

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

21231984

1 reference

29 May 2018